Peel Therapeutics: Closes $9M Financing Round

Peel Therapeutics Closes $9M Financing Round

  • Peel Therapeutics, a Salt Lake City, UT-based clinical-stage biotech company, secured $9M in funding, bringing its total seed financing to $36M
  • The company intends to use the funds to advance clinical and pre-clinical programs
  • PeelTherapeutics is a clinical-stage biotech company that is advancing a therapeutic pipeline to treat a spectrum of devastating conditions, with a near-term focus on cancer and inflammation
  • The company has raised a total of $36M in seed financing, plus over $3M in non-dilutive capital
  • Peel also expanded its Board of Directors to support and guide the company through this rapid growth stage
  • The new additions include Ryan Watts, CEO, Denali Therapeutics and Carin Canale-Theakston, CEO, Evoke Canale
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Cosegic Strengthens Financial Crime Expertise with Fintrail Acquisition

The acquisition enhances Cosegic's capabilities in combating financial crime.Highlights: Cosegic acquires Fintrail to enhance financial crime capabilities.The acquisition...

Keye Launches AI Co-Pilot for Private Equity Due Diligence

A game-changing tool to enhance efficiency in investment evaluations.Highlights: Keye introduces an AI-powered co-pilot for due diligence.Streamlines the...

Regulators Urged to Prioritize Gen AI Threats Over Quantum Computing Risks

Insights on the evolving regulatory landscape in fintech and AI.Highlights: Exchange Association emphasizes urgency on Gen AI regulatory...

Cryptocurrency Scam Losses Surge to $17 Billion in 2025, Fuelled by AI

Analysis reveals AI-driven schemes are escalating crypto fraud incidences.Highlights: Losses from cryptocurrency scams reached $17 billion in 2025.AI...